Skip to main content
Erschienen in: Rheumatology International 4/2014

01.04.2014 | Short Communication

Association between leptin and systemic lupus erythematosus

verfasst von: Wang-Dong Xu, Min Zhang, Yu-Jing Zhang, Shan-Shan Liu, Hai-Feng Pan, Dong-Qing Ye

Erschienen in: Rheumatology International | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Leptin, the product of ob gene, is a 16-kDa nonglycosylated peptide hormone produced by adipocytes that regulates appetite and energy expenditure at the hypothalamic level. As is known to be a satiety factor that can regulate body weight by inhibiting food intake and stimulating energy expenditure, leptin is a pleiotropic hormone whose multiple effects include regulation of endocrine function, reproduction and immunity. Since leptin has been considered to be a pro-inflammatory cytokine, investigations of leptin in the pathogenesis of autoimmune diseases have been detected, such as systemic lupus erythematosus, rheumatoid arthritis and osteoarthritis. Recently, the role of leptin in the modulation of immune response and inflammation has been discussed in the autoimmune diseases increasingly but less in systemic lupus erythematosus (SLE). Therefore, this article will focus on the current understanding of the role of leptin with such similar pathogenic mechanism in SLE in order to provide insights which may assist in the development of leptin-based approaches for the treatment of SLE.
Literatur
1.
Zurück zum Zitat Xu WD, Zhang YJ, Wang W et al (2012) Role of CREM in systemic lupus erythematosus. Cell Immunol 276:10–15PubMedCrossRef Xu WD, Zhang YJ, Wang W et al (2012) Role of CREM in systemic lupus erythematosus. Cell Immunol 276:10–15PubMedCrossRef
2.
Zurück zum Zitat Otero M, Lago R, Lago F et al (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579:295–301PubMedCrossRef Otero M, Lago R, Lago F et al (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579:295–301PubMedCrossRef
3.
Zurück zum Zitat Härle P, Pongratz G, Weidler C et al (2004) Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 63:809–816PubMedCentralPubMedCrossRef Härle P, Pongratz G, Weidler C et al (2004) Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 63:809–816PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Howard JK, Lor GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob./ob. mice. J Clin Invest 104:1051–1059PubMedCentralPubMedCrossRef Howard JK, Lor GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob./ob. mice. J Clin Invest 104:1051–1059PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Carbone F, La Rocca C, Matarese G (2012) Immunological functions of leptin and adiponectin. Biochimie 94:2082–2088PubMedCrossRef Carbone F, La Rocca C, Matarese G (2012) Immunological functions of leptin and adiponectin. Biochimie 94:2082–2088PubMedCrossRef
6.
Zurück zum Zitat Saraf P, Fantuzzi G, Fuler J (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185:171–175CrossRef Saraf P, Fantuzzi G, Fuler J (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185:171–175CrossRef
7.
Zurück zum Zitat Inui A (1999) Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 59:4493–4501PubMed Inui A (1999) Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 59:4493–4501PubMed
8.
Zurück zum Zitat Sierra-Honigmann MR, Nath AK, Murakami C et al (1998) Biological action of leptin as an angiogenic factor. Science 281:1683–1686PubMedCrossRef Sierra-Honigmann MR, Nath AK, Murakami C et al (1998) Biological action of leptin as an angiogenic factor. Science 281:1683–1686PubMedCrossRef
9.
Zurück zum Zitat Vaisse C, Halaas JL, Horvath CM et al (1996) Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95–97PubMedCrossRef Vaisse C, Halaas JL, Horvath CM et al (1996) Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95–97PubMedCrossRef
10.
Zurück zum Zitat van den Brink GR, O’Toole T, Hardwich JC et al (2010) Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen activated protein (MAP) kinase and p70 S6 kinase. Mol Cell Biol Res Commum 4:144–150CrossRef van den Brink GR, O’Toole T, Hardwich JC et al (2010) Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen activated protein (MAP) kinase and p70 S6 kinase. Mol Cell Biol Res Commum 4:144–150CrossRef
11.
Zurück zum Zitat Rose DP, Gilhooly EM, Nixon DW (2002) Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin. Int J Oncol 21:1285–1292PubMed Rose DP, Gilhooly EM, Nixon DW (2002) Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin. Int J Oncol 21:1285–1292PubMed
12.
Zurück zum Zitat Sanna V, Digiacomo A, Lacava A et al (2003) Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 111:241–250PubMedCentralPubMedCrossRef Sanna V, Digiacomo A, Lacava A et al (2003) Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 111:241–250PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Howard JK, Lord GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104:1051–1059PubMedCentralPubMedCrossRef Howard JK, Lord GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104:1051–1059PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Park MC, Lee SW, Choi ST et al (2007) Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 36:101–106PubMedCrossRef Park MC, Lee SW, Choi ST et al (2007) Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 36:101–106PubMedCrossRef
15.
Zurück zum Zitat Busso N, So A, Chobaz-Peclat V et al (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168:875–882PubMed Busso N, So A, Chobaz-Peclat V et al (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168:875–882PubMed
16.
Zurück zum Zitat Olama SM, Senna MK, Elarman M (2012) Synovial/Serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int 32:683–690PubMedCrossRef Olama SM, Senna MK, Elarman M (2012) Synovial/Serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int 32:683–690PubMedCrossRef
17.
Zurück zum Zitat Goswami J, Hernández-Santos N, Zuniga LA et al (2009) A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol 39:2831–2839PubMedCentralPubMedCrossRef Goswami J, Hernández-Santos N, Zuniga LA et al (2009) A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol 39:2831–2839PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Sanctis JD, Zabaleta M, Bianco NE et al (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42:272–274PubMedCrossRef Sanctis JD, Zabaleta M, Bianco NE et al (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42:272–274PubMedCrossRef
19.
Zurück zum Zitat Sada KE, Yamasaki Y, Maruyama M et al (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33:1545–1552PubMed Sada KE, Yamasaki Y, Maruyama M et al (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33:1545–1552PubMed
20.
Zurück zum Zitat Chung CP, Long AG, Solus JF et al (2009) Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 18:799–806PubMedCentralPubMedCrossRef Chung CP, Long AG, Solus JF et al (2009) Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 18:799–806PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Vadacca M, Margiotta D, Rigon A et al (2009) Adipokines and systemic lupus erythematosus: relationship with, metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 36:295–297PubMedCrossRef Vadacca M, Margiotta D, Rigon A et al (2009) Adipokines and systemic lupus erythematosus: relationship with, metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 36:295–297PubMedCrossRef
22.
Zurück zum Zitat Ryan MJ, McLemore GR Jr, Hendrix ST (2006) Insulin resistance and obesity in a mouse model of systemic lupus erythematosus. Hypertension 48:988–993PubMedCrossRef Ryan MJ, McLemore GR Jr, Hendrix ST (2006) Insulin resistance and obesity in a mouse model of systemic lupus erythematosus. Hypertension 48:988–993PubMedCrossRef
23.
Zurück zum Zitat Liu K, Liang C, Liang ZY et al (2005) Sle 1ab mediated the aberrant activation of stat3 and ras-erk signaling pathways in B lymphocytes. J Immunol 174:1630–1637PubMed Liu K, Liang C, Liang ZY et al (2005) Sle 1ab mediated the aberrant activation of stat3 and ras-erk signaling pathways in B lymphocytes. J Immunol 174:1630–1637PubMed
24.
Zurück zum Zitat Miyamoto M, Ono E, Barbosa C et al (2011) Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus. Lupus 20:736–744PubMedCrossRef Miyamoto M, Ono E, Barbosa C et al (2011) Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus. Lupus 20:736–744PubMedCrossRef
25.
Zurück zum Zitat Yu Y, Liu Y, Shi FD et al (2013) Cutting edge: leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol 190:3054–3058PubMedCrossRef Yu Y, Liu Y, Shi FD et al (2013) Cutting edge: leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol 190:3054–3058PubMedCrossRef
26.
Zurück zum Zitat Liu Y, Yu Y, Matarese G et al (2012) Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J Immunol 188:2070–2073PubMedCentralPubMedCrossRef Liu Y, Yu Y, Matarese G et al (2012) Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J Immunol 188:2070–2073PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Sun D, Krishnan A, Su J et al (2004) Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice. Cell Immunol 228:54–65PubMedCrossRef Sun D, Krishnan A, Su J et al (2004) Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice. Cell Immunol 228:54–65PubMedCrossRef
28.
Zurück zum Zitat La Cava A, Ebling FM, Hahn BH (2004) Ig-reactive CD4+ CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol 173:3542–3548PubMed La Cava A, Ebling FM, Hahn BH (2004) Ig-reactive CD4+ CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol 173:3542–3548PubMed
29.
Zurück zum Zitat Xu Z, Cuda CM, Croker BP et al (2011) The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice. Arthritis Rheum 63:764–774PubMedCentralPubMedCrossRef Xu Z, Cuda CM, Croker BP et al (2011) The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice. Arthritis Rheum 63:764–774PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Wang S, Yang N, Zhang L et al (2010) Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice. Lupus 19:1171–1180PubMedCrossRef Wang S, Yang N, Zhang L et al (2010) Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice. Lupus 19:1171–1180PubMedCrossRef
31.
Zurück zum Zitat Tong KM, Shieh DC, Chen CP et al (2008) Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3 K, Akt cascade and promotion of NF-κB/p300 binding in human synovial fibroblasts. Cell Signal 20:1478–1488PubMedCrossRef Tong KM, Shieh DC, Chen CP et al (2008) Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3 K, Akt cascade and promotion of NF-κB/p300 binding in human synovial fibroblasts. Cell Signal 20:1478–1488PubMedCrossRef
32.
Zurück zum Zitat Beşliu AN, Pistol G, Marica CM et al (2009) PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients. Roum Arch Microbiol Immunol 68:69–79PubMed Beşliu AN, Pistol G, Marica CM et al (2009) PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients. Roum Arch Microbiol Immunol 68:69–79PubMed
33.
Zurück zum Zitat Xu WD, Zhang YJ, Xu K et al (2012) IRF7, a functional factor associates with systemic lupus erythematosus. Cytokine 58:317–320PubMedCrossRef Xu WD, Zhang YJ, Xu K et al (2012) IRF7, a functional factor associates with systemic lupus erythematosus. Cytokine 58:317–320PubMedCrossRef
Metadaten
Titel
Association between leptin and systemic lupus erythematosus
verfasst von
Wang-Dong Xu
Min Zhang
Yu-Jing Zhang
Shan-Shan Liu
Hai-Feng Pan
Dong-Qing Ye
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 4/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2774-4

Weitere Artikel der Ausgabe 4/2014

Rheumatology International 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.